Log in to save to my catalogue

Immune-mediated necrotizing myopathy: clinical features and pathogenesis

Immune-mediated necrotizing myopathy: clinical features and pathogenesis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03831009v1

Immune-mediated necrotizing myopathy: clinical features and pathogenesis

About this item

Full title

Immune-mediated necrotizing myopathy: clinical features and pathogenesis

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Rheumatology, 2020-12, Vol.16 (12), p.689-701

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies that was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal recognition particle (anti-SRP) or anti-3-hydroxy-3-methylglutaryl-coA reductase (anti-HMGCR) myositis-specific autoantibodies, although ~20% of patients with IMNM remain sero...

Alternative Titles

Full title

Immune-mediated necrotizing myopathy: clinical features and pathogenesis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03831009v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03831009v1

Other Identifiers

ISSN

1759-4790

E-ISSN

1759-4804

DOI

10.1038/s41584-020-00515-9

How to access this item